BioCentury
ARTICLE | Clinical News

Fibrocell, Intrexon preclinical data

June 15, 2015 7:00 AM UTC

In severe combined immunodeficiency (SCID) mice with human skin grafts, FCX-007 led to no adverse effects in 2- and 6-week toxicology studies. Additionally, Fibrocell said collagen type VII (COL7A1) ...